ICORG’s contribution to the development of an important new drug (PD 0332991) has been recognised in an oral presentation to be given at the San Antonio Breast Cancer Symposium in December 2012.
October is Breast Cancer Awareness month and here at ICORG we are doing our bit by illuminating our office PINK every evening for the entire month.
Ireland is well placed thanks to its national cancer research organisation – ICORG a non-profit cancer research expert group who have been working for 15 years to put Ireland on the international cancer research map and thankfully have succeeded in securing a role for Ireland in some of the most important new international research currently underway in cancer. This communication will describe five breakthrough treatments that are currently or soon to be available in Ireland through an ICORG clinical trial. Today ICORG has 58 clinical research studies open, many of these at all of Ireland’s cancer treating centres.
IPPOSI (Partnership between Patient Organisations, Science and Industry) have just launched information leaflets about taking part in Clinical Trials
Results of the Velcade Mesothelioma (ICORG 05-10) Study have now been published in the Journal of Thoracic Oncology (September 2012 – Volume 7 – Issue 9)
Congratulations to Dr Anne Horgan and the all of the team in Waterford Regional Hospital on the accrual of the first ICORG patient to this important study on the 27th August.
Are you interested in getting regular updates on Cancer Research in Ireland and Cancer related national and international news?
It has been announced that St James’s Hospital has been designated the National Centre for Oesphageal and Gastric Cancer with Professor John Reynolds appointed the Clinical Lead for Upper Gastrointestinal Cancer.
The EU issued, on 17th July 2012, the ‘Clinical Trials Regulation’ proposal which is anticipated to replace the Clinical Trials Directive 2001/20/EC in 2016.
ICORG exceeded their accrual target for IBCSG35-07 (SOLE) / ICORG 11-03 Study